Skip to main content

New Drug Approvals 2012 - Pt. IV - Vismodegib (ERIVEDGETM)

Image
By Bissan Al-Lazikani






Wikipedia: Vismodegib

On Jan 31st 2012 the FDA approved Vismodegib (tradename: ErivedgeTM, previously known as GDC-0449 and HhAntag691) a hedgehog signalling pathway inhibitor for the treatment metastatic basal cell carcinoma.

This is a novel first-in-class medicine, which for the first time modulates the hedgehog pathway. The target of Vismodegib is smoothened (SMO) (UniProt:Q99835, CanSAR:link). SMO is a class F (or class 6) G-Protein Coupled Receptor (GPCR) also known as the Frizzled/Smoothened class (pfam:PF01534). Smoothened is distinct and different to the previously 'drugged' GPCRs (which primarily target class A/class 1 receptors). The 3D-structures of smoothened or any of its homologues have not been characterised and are believed to differ from Class 1 GPCRs.

Vismodegib (Chembl: CHEMBL473417, ChemSpider:23337846 PubChem:CID24776445, IUPAC: 2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide) is a synthetic small molecule drug, and is fully rule-of-five compliant. The molecular weight is 421.3, and has an XlogP of 3.8). Normal dosing is 150 mg per day (equivalent to 356 umol).

Vismodegib is a highly permeable compound with low aqueous solubility (BCS Class 2) - the single dose absolute bioavailability of vismodegib is 31.8%. Absorption of vismodegib is saturable - shown by the lack of dose proportional increase in exposure after a single dose of 270 mg or 540 mg vismodegib.  The volume of distribution (Vd) of vismodegib ranges from 16.4 to 26.6 L, and plasma protein binding is greater than 99% - with binding observed to both human serum albumin (ALB) and alpha-1-acid glycoprotein (also known as Orosomucoid, ORM, AGP and AAG), it is also a substrate of the efflux transporter P-glycoprotein (P-gp). Greater than 98% of the total circulating drug-related components are the parent drug. Minor metabolic pathways of vismodegib in humans include oxidation, glucuronidation, and pyridine ring cleavage. Vismodegib and its metabolites are eliminated primarily by the hepatic route with 82% of the administered dose recovered in the feces and less than 5% in urine. The estimated elimination half-life (t1/2) of vismodegib is 4 days after continuous once-daily dosing, and 12 days after a single dose.

Vismodegib has a boxed warning for potential risk of causing embryonic death and serious birth defects.

The license for Vismodegib is held by Genentech.

Full Prescribing Information can be found here.

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

ChEMBL 34 is out!

By
We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding ...
Post a Comment
Read more

SureChEMBL gets a facelift

By
    Dear SureChEMBL users, Over the past year, we’ve introduced several updates to the SureChEMBL platform, focusing on improving functionality while maintaining a clean and intuitive design. Even small changes can have a big impact on your experience, and our goal remains the same: to provide high-quality patent annotation with a simple, effective way to find the data you need. What’s Changed? After careful consideration, we’ve redesigned the landing page to make your navigation smoother and more intuitive. From top to bottom: - Announcements Section: Stay up to date with the latest news and updates directly from this blog. Never miss any update! - Enhanced Search Bar: The main search bar is still your go-to for text searches, still with three pre-filter radio buttons to quickly narrow your results without hassle. - Improved Query Assistant: Our query assistant has been redesigned and upgraded to help you craft more precise queries. It now includes five operator options: E...
Post a Comment
Read more

Improvements in SureChEMBL's chemistry search and adoption of RDKit

By Eloy
    Dear SureChEMBL users, If you frequently rely on our "chemistry search" feature, today brings great news! We’ve recently implemented a major update that makes your search experience faster than ever. What's New? Last week, we upgraded our structure search engine by aligning it with the core code base used in ChEMBL . This update allows SureChEMBL to leverage our FPSim2 Python package , returning results in approximately one second. The similarity search relies on 256-bit RDKit -calculated ECFP4 fingerprints, and a single instance requires approximately 1 GB of RAM to run. SureChEMBL’s FPSim2 file is not currently available for download, but we are considering generating it periodicaly and have created it once for you to try in Google Colab ! For substructure searches, we now also use an RDKit -based solution via SubstructLibrary , which returns results several times faster than our previous implementation. Additionally, structure search results are now sorted by...
Post a Comment
Read more

Here's a nice Christmas gift - ChEMBL 35 is out!

By
Use your well-deserved Christmas holidays to spend time with your loved ones and explore the new release of ChEMBL 35!            This fresh release comes with a wealth of new data sets and some new data sources as well. Examples include a total of 14 datasets deposited by by the ASAP ( AI-driven Structure-enabled Antiviral Platform) project, a new NTD data se t by Aberystwyth University on anti-schistosome activity, nine new chemical probe data sets, and seven new data sets for the Chemogenomic library of the EUbOPEN project. We also inlcuded a few new fields that do impr ove the provenance and FAIRness of the data we host in ChEMBL:  1) A CONTACT field has been added to the DOCs table which should contain a contact profile of someone willing to be contacted about details of the dataset (ideally an ORCID ID; up to 3 contacts can be provided). 2) In an effort to provide more detailed information about the source of a deposited dat...
Post a Comment
Read more

A python client for accessing ChEMBL web services

By
Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEM...
1 comment
Read more